Paspalum Notatum Pollen - NDC Database
8 records found
Page:
0268-1033 Jan 01, 1965
Paspalum Notatum Pollen .001 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Paspalum Notatum Pollen .001 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-1034 Jan 01, 1965
Paspalum Notatum Pollen .1 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Paspalum Notatum Pollen .1 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-1035 Jan 01, 1965
Paspalum Notatum Pollen .05 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Paspalum Notatum Pollen .05 g/ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-1036 Jan 01, 1965
Paspalum Notatum Pollen 40000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Paspalum Notatum Pollen 40000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-1037 Jan 01, 1965
Paspalum Notatum Pollen 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Paspalum Notatum Pollen 10000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-1038 Jan 01, 1965
Paspalum Notatum Pollen 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
Paspalum Notatum Pollen 20000 [pnu]/Ml Subcutaneous Injection, Solution by Alk-abello, Inc.
0268-6605 Jan 01, 1965
Paspalum Notatum Pollen .05 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
Paspalum Notatum Pollen .05 g/ml Percutaneous Injection, Solution by Alk-abello, Inc.
0268-6682 Jan 01, 1965
Paspalum Notatum Pollen 1000 [pnu]/Ml Intradermal Injection, Solution by Alk-abello, Inc.
Paspalum Notatum Pollen 1000 [pnu]/Ml Intradermal Injection, Solution by Alk-abello, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.